Pricing Log in Create free account
Saturday 17 October 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.

18.66 0.44 +2.41%
Market cap
$20.9B
P/E
0.0×
Fwd P/E
61.1×
Dividend yield
2.57%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Viatris Inc. (VTRS) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Viatris Inc. (VTRS) trades at a EV/Sales of 2.3×. Over the past ten years it has ranged from 1.7× (April 2025) to 5.3× (July 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.7× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.9× (5.29%)
FY2024 2.0× 2.28%
FY2023 2.0× 2.11%
FY2022 2.0× (9.70%)
FY2021 2.2× (33.21%)
FY2020 3.2× 58.22%
FY2019 2.0× (15.00%)
FY2018 2.4× (25.82%)
FY2017 3.3× 0.12%
FY2016 3.2× (3.34%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.1× 8.60%
Mar 2026 1.9× (0.09%)
Dec 2025 1.9× 1.90%
Sep 2025 1.9× 2.23%
42 more quarters

Against its own ten years

Low 1.7× High 5.3×
Ten-year median 2.2×
Current reading's percentile 60

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. 2.3×
RDY Dr. Reddy's Laboratories Ltd compare 2.9×
TAK Takeda Pharmaceutical Co. compare 3.0×
ELAN Elanco Animal Health Incorporated compare 3.0×
HLN Haleon PLC Sponsored ADR compare 3.1×
TEVA Teva Pharmaceutical Industries Ltd. compare 3.5×
NBIX Neurocrine Biosciences, Inc. compare 4.1×
ZTS Zoetis Inc. compare 4.4×
UTHR United Therapeutics Corporation compare 6.5×
Drug Manufacturers Specialty & Generic industry median 2.7×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on VTRS